Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
61.80
-1.15 (-1.83%)
May 28, 2026, 10:48 AM HKT
Nanjing Leads Biolabs Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $110.96 | Buy | Maintains | $110.96 | +79.55% | Apr 28, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $81.01 → $103.06 | Buy | Maintains | $81.01 → $103.06 | +66.76% | Apr 21, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $101.90 → $140.75 | Buy | Maintains | $101.90 → $140.75 | +127.75% | Apr 15, 2026 |
Andy Wang CMB International Securities No rating | CMB International Securities | Buy Maintains $100.50 | Buy | Maintains | $100.50 | +62.62% | Mar 31, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +74.76% | Mar 30, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $94.00 | Buy | Maintains | $94.00 | +52.10% | Dec 1, 2025 |